Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours

AIMS: Acridine orange (AO) demonstrates several biological activities. When exposed to low doses of X-ray radiation, AO increases the production of reactive radicals (radiodynamic therapy (AO-RDT)). We elucidated the efficacy of AO-RDT in breast and prostate cancer cell lines, which are likely to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuyama, Yumi, Nakamura, Tomoki, Yoshida, Keisuke, Hagi, Tomohito, Iino, Takahiro, Asanuma, Kunihiro, Sudo, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582865/
https://www.ncbi.nlm.nih.gov/pubmed/36214462
http://dx.doi.org/10.1302/2046-3758.1110.BJR-2022-0105.R2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582865/
https://www.ncbi.nlm.nih.gov/pubmed/36214462
http://dx.doi.org/10.1302/2046-3758.1110.BJR-2022-0105.R2

Ejemplares similares